Related Experiment Videos
[Advances regarding tumor markers in bladder cancer]
J Moreno Sierra1, G J Chicharro Almarza, J M Torronteras Santiago
1Cátedra de Urología, Hospital Universitario San Carlos, Madrid.
Actas Urologicas Espanolas
|March 1, 1997
Summary
This study investigated tumor markers for bladder cancer, finding that CEA and CA 50 levels can help predict prognosis in patients with transitional cell vesical carcinoma. Further research is needed to identify definitive markers for invasive potential.
Area of Science:
- Urothelial Carcinoma Research
- Tumor Marker Analysis
- Oncological Diagnostics
Context:
- Bladder cancer lacks specific tumor markers to predict invasiveness.
- Current diagnostic methods for vesical carcinoma require improvement in predicting tumor progression.
Purpose:
- To evaluate the diagnostic and prognostic potential of serum and tissue levels of Carcinoembryonic antigen (CEA), CA 50, CA 19.9, and Tissue Polypeptide Specific Antigen (TPS) in vesical carcinoma.
- To determine if these biological substances can differentiate between superficial and invasive bladder tumors.
Summary:
- Analysis of serum and tissue samples from 190 bladder cancer patients and 58 controls revealed elevated CEA and CA 50 levels in patients, particularly those with invasive tumors.
- Higher TPS levels were observed in bladder tumor tissues and sera. CA 19.9 showed lower serum levels but higher tissue levels in cancer patients.
- CEA and CA 50 levels in serum and tissue are significantly higher in bladder cancer patients, especially with invasive disease, indicating their potential as prognostic markers.
Impact:
- Identifies CEA and CA 50 as potential prognostic factors for bladder cancer, aiding in clinical decision-making.
- Provides insights into the utility of tumor markers in distinguishing tumor stages and predicting invasiveness.
- Contributes to the development of more effective diagnostic and monitoring strategies for vesical carcinoma.